INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,806 | +11.2% | 152 | +43.4% | 0.00% | 0.0% |
Q2 2023 | $4,323 | +0.9% | 106 | -7.8% | 0.00% | 0.0% |
Q1 2023 | $4,286 | -30.2% | 115 | -34.7% | 0.00% | 0.0% |
Q4 2022 | $6,141 | -52.8% | 176 | -22.5% | 0.00% | -66.7% |
Q3 2022 | $13,000 | +8.3% | 227 | -5.4% | 0.00% | +50.0% |
Q2 2022 | $12,000 | -33.3% | 240 | -4.4% | 0.00% | -33.3% |
Q1 2022 | $18,000 | -14.3% | 251 | +38.7% | 0.00% | -25.0% |
Q4 2021 | $21,000 | -40.0% | 181 | -30.4% | 0.00% | -42.9% |
Q3 2021 | $35,000 | +25.0% | 260 | +47.7% | 0.01% | +16.7% |
Q2 2021 | $28,000 | +100.0% | 176 | +2.3% | 0.01% | +100.0% |
Q1 2021 | $14,000 | -22.2% | 172 | -49.4% | 0.00% | +50.0% |
Q4 2020 | $18,000 | – | 340 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |